Neurizon Therapeutics Limited (“Neurizon”), a clinical-stage biotech company dedicated to advancing treatments for ...

“This confirmation by our talented team of researchers demonstrates that fibroblasts can support the regeneration of myelin sheath, marking a potentially significant step in the utilization of a ...

Tessara’s RealBrain technology replicates the human brain’s complexity, and Neurizon is utilizing these models to explore NUZ ...

Neurizon Therapeutics Ltd (ASX:NUZ) has yielded positive results from an independent study – conducted in collaboration with ...

In this interview, Sebastiaan J. Trietsch, Chief Technology Officer at MIMETAS, discusses how microphysiological systems are ...

The global human organoid market has garnered considerable attention in recent years, emerging as one of the most promising ...

Parkinson's doesn't just affect movement and the brain—it may also impact the heart, according to new research from the ...

The study is useful for advancing spatial transcriptomics through its novel regression-based linear model (glmSMA) that integrates single-cell RNA-seq with spatial reference atlases, though its ...

Researchers at the University of Surrey discovered that Parkinson’s-related alpha-synuclein accumulates in the heart’s nerve ...

Mach 7 and Universal Biosensors have announced their CEOs will depart, while changes at the top are likely at other biotechs.

Early signs of one of the most common reproductive cancers may now be spotted with near-perfect accuracy, thanks to a groundbreaking artificial intelligence model. For years, diagnosing endometrial ...